Complement System in SLE as a Target for Antibodies

By  

Current Rheumatology Reviews, Vol. 9, Iss. 1, 2013-02 ,pp. : 34-44

Bentham Science Publishers

Access to resources Recommend Favorite

C1q complement component and -antibodies reflect SLE activity and kidney involvement

By Horák P.   Heřmanová Z.   Zadražil J.   Ciferská H.   Ordeltová M.   Kusá L.   Žurek M.   Tichý T.  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 532-536

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic Utility of Systematic Aquaporin-4 Antibodies Determination in the First Event of Immune-Mediated Optic Neuritis

By  

European Neurology, Vol. 76, Iss. 5-6, 2016-10 ,pp. : 227-233

Karger

Access to resources Recommend Favorite

Antiganglioside GM1 Antibodies and Their Complement Activating Capacity in Central and Peripheral Nervous System Disorders and in Controls

By  

European Neurology, Vol. 39, Iss. 2, 1998-02 ,pp. : 103-110

Karger

Access to resources Recommend Favorite

Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis

By Abdel-Nasser A. M.   Mahmoud M. H.   El Mansoury T. M.   Osman A. M.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 329-336

Informa Healthcare

Access to resources Recommend Favorite